XML 82 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
segment
Dec. 31, 2021
USD ($)
Net revenue $ 18,930 $ 4,133
Construction in progress $ 692 420
Payment term 30 days  
Allowance for credit loss on accounts receivable $ 71  
Number of reportable segments | segment 2  
Diagnostics    
Net revenue $ 391 125
Diagnostics | Consumables    
Net revenue 391 125
Therapeutics    
Net revenue 18,539 4,008
Therapeutics | Consumables    
Net revenue 2,072  
Therapeutics | Instruments    
Net revenue 7,269 1,793
Therapeutics | Trodes    
Net revenue 8,681 2,073
Therapeutics | Other revenue    
Net revenue $ 517 $ 142